Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

467.35 +6.21 (+1.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

70 71 Next >

Navigating the Currents: Top Sectors Primed for Growth in Q3 2025

August 27, 2025

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,...

Via MarketMinute

What's Driving the Market Sentiment Around Vertex Pharmaceuticals? ↗

August 27, 2025

Via Benzinga

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Prime Candidate for Value Investors ↗

August 26, 2025

Vertex Pharmaceuticals (VRTX) is a top value stock with strong financials, high profitability, and impressive growth, trading below its biotech peers.

Via Chartmill

Vertex Pharmaceuticals Unusual Options Activity ↗

August 06, 2025

Via Benzinga

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy? ↗

August 24, 2025

It's been an unusually bad year for this drugmaker, but it's essential to look beyond that.

Via The Motley Fool

Topics Law Enforcement Stocks

2 Beaten-Down Stocks With Incredible Upside Potential ↗

August 22, 2025

These stocks should be able to rebound strongly.

Via The Motley Fool

Vertex to Participate in Upcoming September Investor Conferences

August 20, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

What's Wrong With Vertex Pharmaceuticals Stock? ↗

August 20, 2025

Shares of the pharma company are down 17% in the past 12 months.

Via The Motley Fool

2 Nasdaq 100 Stocks to Consider Right Now and 1 Facing Challenges

August 19, 2025

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing...

Via StockStory

Trump 2.0 At 200 Days: Palantir Surges, Tesla Slumps ↗

August 18, 2025

Palantir leads all stocks in the S&P 500 with a stunning 160% gain in Trump's first 200 days.

Via Benzinga

Topics Government Stocks

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns ↗

August 17, 2025

This biotech's innovative approach could pay rich dividends down the road.

Via The Motley Fool

3 Fantastic Growth Stocks to Buy in August ↗

August 17, 2025

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Via The Motley Fool

Is This Beaten-Down Stock a Buy on the Dip? ↗

August 15, 2025

It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point.

Via The Motley Fool

2 Growth Stocks That Are No-Brainer Buys Right Now ↗

August 15, 2025

These stocks have outperformed broader equities over the past decade and still have room to run.

Via The Motley Fool

VRTX Q2 2025 Deep Dive: New Product Launches and Pipeline Update in a Volatile Market

August 12, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $2.96 billion. The company expects the...

Via StockStory

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today ↗

August 11, 2025

Via Benzinga

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗

August 11, 2025

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

August 11, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

1 Cash-Producing Stock for Long-Term Investors and 2 We Brush Off

August 11, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Gartner, Eli Lilly, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (August 4-August 8): Are The Others In Your Portfolio? ↗

August 10, 2025

Large-cap laggards slid on weak results/guidance, cuts and capital moves—led by The Trade Desk, Fortinet, Super Micro, Gartner and Eli Lilly.

Via Benzinga

The Smartest Growth Stocks to Buy With $1,000 Right Now ↗

August 09, 2025

There's no guarantee that any stock will beat the market, but the chances look good for these three.

Via The Motley Fool

Topics Artificial Intelligence

5 Top Stocks to Buy in August ↗

August 08, 2025

Even with the S&P 500 near an all-time high, there are plenty of compelling growth, dividend, and value stocks to buy now.

Via The Motley Fool

Topics Economy Stocks

Unusual volume S&P500 stocks in Thursday's session ↗

August 07, 2025

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Via Chartmill

The Best Stocks to Invest $1,000 In Right Now ↗

August 07, 2025

Market volatility could increase in the months ahead, but these stocks should hold up well.

Via The Motley Fool

Topics Economy Government World Trade

Which S&P500 stocks have an unusual volume on Wednesday? ↗

August 06, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

August 06, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Strong Affordable Growth Pick with Solid Fundamentals ↗

August 06, 2025

Vertex Pharmaceuticals (VRTX) offers strong growth, solid profitability, and reasonable valuations, making it a top pick for affordable growth investors.

Via Chartmill

7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip ↗

August 06, 2025

There's more good news than bad news for this big biotech stock.

Via The Motley Fool

Topics Earnings

Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations ↗

August 06, 2025

A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red.

Via Chartmill

Topics Economy

Why Vertex Pharmaceuticals (VRTX) Stock Is Trading Lower Today

August 05, 2025

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) fell 17.4% in the afternoon session after the company announced its experimental pain drug, VX-993, failed a key mid-stage clinical trial....

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Vertex Pharmaceuticals (NQ:VRTX)

All News about Vertex Pharmaceuticals